Disturbing Cholesterol/Sphingolipid Metabolism by Squalene Epoxidase Arises Crizotinib Hepatotoxicity (Adv. Sci. 14/2025)

Hao Yan; Xiangliang Huang; Yourong Zhou; Yuan Mu; Shaoyin Zhang; Yashi Cao; Wentong Wu; Zhifei Xu; Xueqin Chen; Xiaochen Zhang; Xiaohong Wang; Xiaochun Yang; Bo Yang; Qiaojun He; Peihua Luo

doi:10.1002/advs.202570098

journal article·2025-04Open access

Disturbing Cholesterol/Sphingolipid Metabolism by Squalene Epoxidase Arises Crizotinib Hepatotoxicity (Adv. Sci. 14/2025)

Hao Yan, Xiangliang Huang, Yourong Zhou, Yuan Mu, Shaoyin Zhang, Yashi Cao, Wentong Wu, Zhifei Xu, Xueqin Chen, Xiaochen Zhang, Xiaohong Wang, Xiaochun Yang, Bo Yang, Qiaojun He, Peihua Luo

Advanced Science· Volume 12· Issue 14

Publisher page Open full text

Source abstract

Abstract

Crizotinib Hepatotoxicity In article number 2414923, Peihua Luo, Hao Yan, Xiangliang Huang, and co-workers report the mechanism of crizotinib hepatotoxicity, wherein crizotinib disturbs normal lipid metabolism through accumulation of squalene epoxidase (SQLE). The liver damage caused by crizotinib is similar to persistent sunshine exposure, which causes desertification changes in the “liver land,” whereas rainfall (representing metformin and terbinafine) can prevent such alterations.

Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Pharmacological Effects of Natural Compounds · Endoplasmic Reticulum Stress and Disease · Sphingolipid Metabolism and Signaling

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References

Reference metadata was not supplied for this record.